MARZO, TIZIANO
 Distribuzione geografica
Continente #
NA - Nord America 2.788
EU - Europa 1.415
AS - Asia 354
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4.559
Nazione #
US - Stati Uniti d'America 2.777
PL - Polonia 517
IT - Italia 311
IE - Irlanda 230
HK - Hong Kong 126
SE - Svezia 121
CN - Cina 98
RU - Federazione Russa 90
SG - Singapore 53
JO - Giordania 42
GB - Regno Unito 36
FI - Finlandia 23
DE - Germania 22
UA - Ucraina 14
BE - Belgio 13
VN - Vietnam 13
ES - Italia 11
CA - Canada 10
CH - Svizzera 10
IN - India 8
FR - Francia 6
BG - Bulgaria 5
TR - Turchia 5
AT - Austria 3
IQ - Iraq 3
JP - Giappone 3
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
KR - Corea 1
LK - Sri Lanka 1
MX - Messico 1
NL - Olanda 1
QA - Qatar 1
Totale 4.559
Città #
Warsaw 516
Fairfield 505
Chandler 250
Woodbridge 245
Ashburn 243
Dublin 230
Seattle 208
Houston 188
Cambridge 182
Wilmington 156
Ann Arbor 120
Florence 92
Lawrence 89
Altamura 87
Hong Kong 78
Princeton 68
New York 54
Beijing 49
Boston 43
Singapore 29
Buffalo 27
Medford 24
Moscow 22
Shanghai 22
Boardman 16
San Diego 14
Brussels 13
Barcelona 11
Bern 10
Los Angeles 10
Dong Ket 9
Kent 9
Serra 8
Toronto 8
Falls Church 7
Jacksonville 7
London 7
Norwalk 7
Pisa 5
Sofia 5
Cagliari 4
Fiesole 4
Hillsboro 4
Messina 4
Poppi 4
Valeggio Sul Mincio 4
Washington 4
Andover 3
Castelliri 3
Clifton 3
Laurel 3
New Delhi 3
Phoenix 3
Rome 3
Vienna 3
Arezzo 2
Baghdad 2
Boulder 2
Casarza Ligure 2
Guangzhou 2
Hounslow 2
Jiaxing 2
Kunming 2
Livorno 2
Lucca 2
Milan 2
Nanjing 2
Oiwakeminami 2
Parma 2
Prato 2
Pune 2
Rui'an 2
Strasbourg 2
West Jordan 2
Acton 1
Auburn Hills 1
Bethesda 1
Blue Point 1
Bochum 1
Bogotá 1
Bremen 1
Cagli 1
Calgary 1
Cantagallo 1
Cardiff 1
Catania 1
Cedar Knolls 1
Chiari 1
Frankfurt Am Main 1
Fuzhou 1
Groningen 1
Huzhou 1
Impruneta 1
Islington 1
Kiel 1
Kirkuk 1
Kowloon 1
Lappeenranta 1
Levanto 1
Napoli 1
Totale 3.789
Nome #
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes 237
FROM CONVENTIONAL TO NOVEL Pt-BASED ANTINEOPLASTIC AGENTS: MECHANISTIC ASPECTS AND BIOLOGICAL EFFECTS 228
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 221
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 211
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 169
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 141
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 132
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 130
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 128
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 124
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 111
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 104
Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(I)–NHC complex 101
Reaction with proteins of a five-coordinate platinum(II) compound 101
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins 101
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 100
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 98
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 94
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 92
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 90
Diruthenium Diacetate-Catalyzed Aerobic Oxidation of Hydroxylamines and Improved Chemoselectivity by Immobilization to Lysozyme 88
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 88
The cisplatin/serum albumin system: A reappraisal 85
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 80
Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis 79
Oxaliplatin vs. cisplatin: Competition experiments on their binding to lysozyme 76
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 75
Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies 75
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 75
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 71
Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy 70
The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme 69
Peculiar Features in the Crystal Structure of the Adduct Formed betweencis-PtI2(NH3)2and Hen Egg White Lysozyme 69
Synthesis and Mode of Action Studies on Iridium(I)–NHC Anticancer Drug Candidates 67
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 63
cis-Pt I2(NH3)2: a reappraisal 61
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 61
Interactions between Anticancertrans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts oftrans-(Dimethylamino)(methylamino)dichloridoplatinum(II) 60
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 58
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts 56
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex 53
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 53
null 47
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity 41
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 39
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 39
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 36
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 33
null 31
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 31
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin 29
Mechanistic studies on cytotoxic gold compounds 27
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 27
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study 26
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 20
Totale 4.671
Categoria #
all - tutte 14.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.110 0 91 39 83 153 145 132 147 126 88 83 23
2020/2021622 47 61 15 71 32 44 30 36 90 116 48 32
2021/2022403 5 25 32 13 28 16 11 48 28 25 52 120
2022/20231.056 101 254 44 77 61 175 144 50 93 7 24 26
2023/2024412 16 32 64 10 21 91 24 95 9 19 13 18
2024/2025137 86 51 0 0 0 0 0 0 0 0 0 0
Totale 4.671